Remy Cointreau advances in first nine months of the year
Select language to see a machine translation of this article. The original language of the Article is English and the translation is provided for your convenience.

Remy Cointreau advances in first nine months of the year

On Friday, Remy Cointreau released results for the first nine months of the year that show a slight slowdown from the first half, but an advance on the same period a year ago. The company said that sales in the third quarter were up by 3.2% against a “high basis of comparison”. For reference, the first quarter saw a rise in sales of 8%, while the second quarter saw an increase of 6.2%. All of these figures are reported against the same period in the previous year.

graph 0125 remy

While the news didn’t please all commentators, it should be remembered that all these numbers are positive. The group’s top line has risen by 5.5% thus far against the previous year, and could suffer a fourth-quarter decline in sales of as much as 18% while still hitting parity with fiscal 2016. For that to happen would require serious difficulties for the drinks company – yet, if anything, the company stands to benefit from some positive trends in the fourth quarter.

Remy’s share price has appreciated by 46% over the past 12 months

graph 0125 remy 2

SOURCE: Yahoo Finance

Chief amongst those trends is the continued recovery in China. With Chinese New Year on the way, this is likely to be exacerbated, and Remy will likely see stronger performance in the country. Additionally, Remy has a very strong showing in both premium spirits and brown spirits (with a lot of overlap between the two). Drinkers, who are drinking more globally than ever before, are showing strong preference for both of these segments.

Disclosure

Dominion holds Remy Cointreau in its Global Trends Luxury Fund.


If you would you like to receive the Newsfeeds daily, please click here to sign up now!

Help us make this Newsfeed better by rating this article. 1 star = Poor and 5 stars = Excellent
0.0/5 rating (0 votes)

Disclaimer
The views expressed in this article are those of the author at the date of publication and not necessarily those of Dominion Fund Management Limited. The content of this article is not intended as investment advice and will not be updated after publication. Images, video, quotations from literature and any such material which may be subject to copyright is reproduced in whole or in part in this article on the basis of Fair use as applied to news reporting and journalistic comment on events.